Published in Vaccine Weekly, April 19th, 2006
According to recent research published in the journal Urologia Internationalis, "This review summarizes recent findings on the therapeutic benefits of biphosphonates in patients with advanced prostate or RCC. The role of biphosphonates in ADT-induced osteoporosis and delay of skeletal-related events (SREs) in metastatic bone disease is discussed."
"A brief overview on the proposed modes of action is given. Literature search of PubMed documented publications and abstracts from meetings [was conducted]. Among the biphosphonates currently available,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly